drug

icosapent ethyl

1 story · latest Jul 29, 2026

Status: FDA approved Jul 2012 · NDA202057
Brand: Vascepa

Relationships

Developed by Amarin Corp Plc\Uk

Timeline

Amarin posts Q2 2026 results as international partner sales grow, US expenses fall

Jul 29Quarterly updateAmarin Corp Plc\Uk icosapent ethyl

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.